INTERIM REPORT 202319
Other InformationSUBSTANTIAL SHAREHOLDERS ’ INTERESTS AND SHORT POSITIONS IN SHARES AND 
UNDERLYING SHARES OF THE COMPANY
As of June 30, 2023, so far as the Directors are aware, the following persons (other than the Directors or 
chief executive of the Company) had or were deemed or taken to have interests or short positions in the 
Shares or underlying Shares of the Company which would fall to be disclosed to the Company and the Stock 
Exchange under the provision of Divisions 2 and 3 of Part XV of the SFO or which were recorded in the 
register required to be kept by the Company pursuant to Section 336 of the SFO:
Long positions in the Shares or underlying Shares of the Company
Name of shareholder Nature of interestTotal number 
of Shares/
underlying 
sharesApproximate 
percentage in 
shareholding(8)
6 Dimensions Capital (Note 1) Beneficial interest 119,890,000 17.36%
6 Dimensions Affiliates (Note 1) Beneficial interest 6,310,000 0.91%
6 Dimensions Capital GP, LLC (Note 1) Interest in controlled corporation 126,200,000 18.27%
Suzhou Frontline II (Note 2) Beneficial interest 88,340,000 12.79%
Suzhou Fuyan Venture Capital Management Partnership 
 (Limited Partnership) ( ᘽψబض௴ุҳ༟၍ଣΥྫΆุ
 (ϞࠢΥྫ )) (Note 2)Interest in controlled corporation 88,340,000 12.79%
Suzhou 6 Dimensions (Note 2) Beneficial interest 37,860,000 5.48%
Suzhou Tongyu Investment Management Partnership 
 (Limited Partnership) ( ᘽψஷ๎ҳ༟၍ଣΥྫΆุ
 (ϞࠢΥྫ )) (Note 2)Interest in controlled corporation 37,860,000 5.48%
Suzhou Yunchang Investment Consulting Co., Ltd. 
 (ᘽψᘾڗҳ༟ፔ༔Ϟࠢʮ̡ ) (Note 2)Interest in controlled corporation 126,200,000 18.27%
Ziqing CHEN ( ௓૔ࡠ( ) Note 2) Interest in controlled corporation 126,200,000 18.27%
Summer Iris Limited (Note 3) Beneficial interest 78,214,230 11.32%
Boyu Capital Fund IV, L.P. (Note 3) Interest in controlled corporation 78,214,230 11.32%
Boyu Capital General Partner IV, Ltd. (Note 3) Interest in controlled corporation 78,214,230 11.32%
Boyu Capital Group Holdings Ltd. (Note 3) (Note 4) Interest in controlled corporation 81,629,730 11.82%
TLS Beta Pte. Ltd. (Note 5) Beneficial interest 54,169,400 7.84%
Temasek Life Sciences Private Limited (Note 5) Interest in controlled corporation 54,169,400 7.84%
Fullerton Management Pte Ltd (Note 5) Interest in controlled corporation 54,169,400 7.84%
Temasek Holdings (Private) Limited (Note 5) (Note 6) Interest in controlled corporation 59,446,400 8.61%
Capital Research and Management Company  (Note 7) Beneficial interest 47,735,966 6.91%
The Capital Group Companies, Inc. (Note  7) Interest in controlled corporation 47,735,966 6.91%
    
%**page19**%

OCUMENSION THERAPEUTICS20
Other InformationNotes:
(1) For the purpose of the SFO, 6 Dimensions Capital GP, LLC, as the general partner of each of 6 Dimensions Capital and 6 Dimensions 
Affiliates, is deemed to have an interest in the Shares held by each of 6 Dimensions Capital and 6 Dimensions Affiliates.
(2) Suzhou Fuyan Venture Capital Management Partnership (Limited Partnership) ( ᘽψబض௴ุҳ༟၍ଣΥྫΆุ (ϞࠢΥྫ )) is the general 
partner of Suzhou Frontline II. Suzhou Tongyu Investment Management Partnership (Limited Partnership) ( ᘽψஷ๎ҳ༟၍ଣΥྫΆุ (Ϟࠢ
Υྫ )) is the general partner of Suzhou 6 Dimensions. Suzhou Yunchang Investment Consulting Co., Ltd. ( ᘽψᘾڗҳ༟ፔ༔Ϟࠢʮ̡ ) is 
the general partner of each of Suzhou Fuyan Venture Capital Management Partnership (Limited Partnership) ( ᘽψబض௴ุҳ༟၍ଣΥྫΆ
ุ(ϞࠢΥྫ )) and Suzhou Tongyu Investment Management Partnership (Limited Partnership) ( ᘽψஷ๎ҳ༟၍ଣΥྫΆุ (ϞࠢΥྫ )), and 
is wholly held by Ziqing CHEN ( ௓૔ࡠ .) Ziqing CHEN ( ௓૔ࡠ ) is the father-in-law of Dr. Lian Yong CHEN, the Chairman and non-executive 
Director of our Company.
For the purpose of the SFO, (i) Suzhou Fuyan Venture Capital Management Partnership (Limited Partnership) ( ᘽψబض௴ุҳ༟၍ଣΥ
ྫΆุ (ϞࠢΥྫ )) is deemed to have an interest in the Shares held by Suzhou Frontline II; (ii) Suzhou Tongyu Investment Management 
Partnership (Limited Partnership) ( ᘽψஷ๎ҳ༟၍ଣΥྫΆุ (ϞࠢΥྫ )) is deemed to have an interest in the Shares held by Suzhou 6 
Dimensions; and (iii) Ziqing CHEN ( ௓૔ࡠ ) and Suzhou Yunchang Investment Consulting Co., Ltd. ( ᘽψᘾڗҳ༟ፔ༔Ϟࠢʮ̡ ) are deemed 
to have an interest in the Shares held by each of Suzhou Frontline II and Suzhou 6 Dimensions.
(3) For the purpose of the SFO, each of Boyu Capital Fund IV, L.P. (as the sole shareholder of Summer Iris Limited), Boyu Capital General 
Partner IV, Ltd. (as the general partner of Boyu Capital Fund IV, L.P.) and Boyu Capital Group Holdings Ltd. (as the sole shareholder of 
Boyu Capital General Partner IV, Ltd.) is deemed to have an interest in the 78,214,230 Shares held by Summer Iris Limited.
(4) For the purpose of the SFO, Boyu Capital Group Holdings Ltd. is deemed to have an interest in the 3,415,500 Shares held by Boyu Capital 
Opportunities Master Fund, as Boyu Capital Opportunities Master Fund is managed by Boyu Capital Investment Management Limited, 
which in turn is ultimately controlled by Boyu Capital Group Holdings Ltd.
(5) TLS Beta Pte. Ltd. is a wholly-owned subsidiary of Temasek Life Sciences Private Limited, which is in turn a wholly-owned subsidiary of 
Fullerton Management Pte Ltd, which is in turn a wholly-owned subsidiary of Temasek Holdings (Private) Limited. Under the SFO, Temasek 
Life Sciences Private Limited, Fullerton Management Pte Ltd and Temasek Holdings (Private) Limited are deemed to be interested in the 
54,169,400 Shares held by TLS Beta Pte. Ltd.
(6) For the purpose of the SFO, Temasek Holdings (Private) Limited is deemed to have an interest in the 5,277,000 Shares held by Aranda 
Investments Pte. Ltd., which in turn is ultimately controlled by Temasek Holdings (Private) Limited.
(7) Capital Research and Management Company is a wholly-owned subsidiary of The Capital Group Companies, Inc. For the purpose of 
the SFO, The Capital Group Companies, Inc. is deemed to have an interest in the 47,735,966 Shares held by Capital Research and 
Management Company.
(8) The calculation is based on the total number of 690,711,280 Shares in issue as of June 30, 2023.
Save as disclosed above, as of June 30, 2023, the Company has not been notified of any other relevant 
interests or short positions in the issued share capital of the Company, other than the Directors and chief 
executive  of the Company,  which  would  fall to be disclosed  to the Company  under  the provisions  of 
Divisions 2 and 3 of Part XV of the SFO, or which were recorded in the register required to be kept by the 
Company under Section 336 of the SFO.
SHARE SCHEMES
During the period ended June 30, 2023 and up to the date of this interim report, we have four share 
schemes in effect which were required to be disclosed under the requirements of Chapter 17 of the Listing 
Rules.
Employee Stock Option Plan
The ESOP was adopted by the Company on May 23, 2018 and amended from time to time. Subject to the 
terms of the ESOP, the Board may at its discretion specify any conditions which must satisfied before the 
option(s) under the ESOP may be exercised.  Further details of the ESOP are set out in the Prospectus and our 
2022 annual report.
%**page20**%

